Vascular Dementia: From Pathophysiology to Therapeutic Frontiers
Journal of Clinical Medicine · 19.09.2025 · 14 (18) · 6611
DOI: 10.3390/jcm14186611 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.09.2025. Verfasst von Han-Mo Yang. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Seoul National University Hospital.
Themen: Demenz
Abstract (Originalsprache)
Vascular dementia (VaD) represents the second-most common dementia type after Alzheimer’s disease since it results from complications of cerebrovascular disease. Mixed pathologies combining vascular and neurodegenerative processes are the rule rather than exception in elderly dementia patients. The condition known as VaD includes various types of vascular damage that affect both large and small blood vessels in the brain which results in cerebral hypoperfusion, blood–brain barrier disruption, glymphatic dysfunction, and molecular cascades causing neuronal damage. The mechanisms of VaD include endothelial dysfunction, oxidative stress, chronic neuroinflammation, impaired glymphatic clearance, white matter demyelination, and synaptic failure. The disease susceptibility of individuals depends on genetic factors which include NOTCH3 mutations and vascular risk polymorphisms. The diagnostic field uses neuroimaging tools and fluid biomarkers such as neurofilament light chain, inflammatory markers, and Aβ/tau ratios for mixed pathology. The current practice of vascular risk management combines with new therapeutic approaches that use phosphodiesterase inhibitors for cerebral perfusion and NLRP3 inflammasome inhibitors for neuroinflammation, senolytics for cellular senescence, and remyelination agents for white matter repair. However, the majority of new treatment methods remain investigational with limited Phase III data. Future medical treatment development will depend on precision medicine approaches which use biomarker-guided treatment selection and combination strategies targeting multiple pathological mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
ORCID-Profile: Han-Mo Yang
Förderung
- Seoul National University Hospital
Zitieren
APA
Yang, H. M. (2025). Vascular Dementia: From Pathophysiology to Therapeutic Frontiers. Journal of Clinical Medicine, 14(18), 6611. https://doi.org/10.3390/jcm14186611
Vancouver
Yang HM. Vascular Dementia: From Pathophysiology to Therapeutic Frontiers. Journal of Clinical Medicine. 2025;14(18):6611. doi:10.3390/jcm14186611
BibTeX
@article{Yang2025,
author = {Yang, Han-Mo},
title = {Vascular Dementia: From Pathophysiology to Therapeutic Frontiers},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {18},
pages = {6611},
doi = {10.3390/jcm14186611}
}
EUVIMED